NVRO Nevro Corp

  1. Stocks
  2. Healthcare
  3. NYSE: NVRO

Price (delayed)

$31.215

Market cap

$1.11B

P/E Ratio

390.19

Dividend/share

N/A

EPS

$0.08

Enterprise value

$1.19B

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
The net income has soared by 138% from the previous quarter and by 102% YoY
The EPS has surged by 132% since the previous quarter and by 102% year-on-year
The debt is up by 18% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://www.nevro.com
Peers: ISRG TMO OFIX

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
35.54M
Market cap
$1.11B
Enterprise value
$1.19B
Valuations
Price to earnings (P/E)
390.19
Price to book (P/B)
3.41
Price to sales (P/S)
2.71
EV/EBIT
110.83
EV/EBITDA
56.39
EV/Sales
2.92
Earnings
Revenue
$406.37M
EBIT
$10.7M
EBITDA
$21.02M
Free cash flow
$17.13M
Per share
EPS
$0.08
Free cash flow per share
$0.49
Book value per share
$9.14
Revenue per share
$11.51
TBVPS
$17.06
Balance sheet
Total assets
$602.41M
Total liabilities
$278.53M
Debt
$197.16M
Equity
$323.88M
Working capital
$483.73M
Liquidity
Debt to equity
0.61
Current ratio
7.11
Quick ratio
5.73
Net debt/EBITDA
3.62
Margins
EBITDA margin
5.2%
Gross margin
68%
Net margin
0.7%
Operating margin
1.5%
Efficiency
Return on assets
0.5%
Return on equity
1.1%
Return on invested capital
1.8%
Return on capital employed
2%
Return on sales
2.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
-0.43%
1 week
3.46%
1 month
-6.15%
1 year
-54.53%
YTD
-21.17%
QTD
-21.17%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$406.37M
Gross profit
$276.37M
Operating income
$6.16M
Net income
$3M
Gross margin
68%
Net margin
0.7%
The net income has soared by 138% from the previous quarter and by 102% YoY
The net margin has soared by 135% since the previous quarter and by 102% year-on-year
NVRO's operating income has soared by 106% YoY
The operating margin has soared by 105% YoY

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
390.19
P/B
3.41
P/S
2.71
EV/EBIT
110.83
EV/EBITDA
56.39
EV/Sales
2.92
The EPS has surged by 132% since the previous quarter and by 102% year-on-year
NVRO's P/B is 68% below its 5-year quarterly average of 10.6 and 49% below its last 4 quarters average of 6.7
The equity has grown by 7% YoY
The P/S is 66% lower than the 5-year quarterly average of 8.0 and 40% lower than the last 4 quarters average of 4.5
The revenue has grown by 5% YoY and by 2.8% from the previous quarter

Efficiency

How efficient is Nevro business performance
NVRO's return on equity has surged by 138% since the previous quarter and by 103% year-on-year
The ROA has soared by 136% from the previous quarter and by 102% YoY
The company's return on invested capital has surged by 110% YoY
The return on sales has surged by 109% year-on-year

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 116% greater than its total liabilities
Nevro's current ratio has increased by 10% YoY
NVRO's quick ratio is up by 9% year-on-year
The debt is 39% smaller than the equity
The debt is up by 18% year-on-year
The debt to equity has increased by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.